Israeli biomed named one of 3 top startups in world
Matricelf, which is developing a revolutionary solution for spinal cord paralysis, placed third in the 2022 Startup World Cup.
Matricelf, which is developing a revolutionary solution for spinal cord paralysis, placed third in the 2022 Startup World Cup.
First-ever spinal cord implant to treat paralysis without risk of rejection is successfully tested on mice; human trials expected by end of 2024.
Regenerative medicine company Matricelf will compete in San Francisco as part of a global competition sponsored by Pegasus Tech Ventures.